Pacific Biosciences of California (PACB) Research Hub

Pacific Biosciences of California (PACB) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 2.25 USD (+6.64%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.21, market cap 0.43B. This hub links to the full technical, earnings and options research available for PACB.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNASDAQ, US
Last close2.25 USD (+6.64%)
52-week range1.1 USD – 3.44 USD
Trend regimeRange
14-day RSI37.1 (Bearish)
Trailing P/E-3.21
Market cap0.43B
Dividend yield0.00%
Next earnings2026-08-03

Available research for PACB

Earnings

PACB earnings date and last-quarter result: next report 2026-08-03, last quarter beat, P/E -3.21. Updated 2026-07-23.

Options: Covered Call

Covered Call on PACB: how it works, illustrative setup around the real 2.25 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on PACB: how it works, illustrative setup around the real 2.25 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on PACB: how it works, illustrative setup around the real 2.25 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

PACB technical analysis: range, last 2.25 USD, RSI 37.1, 52w range 1.1 USD–3.44 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is PACB in?

Pacific Biosciences of California (PACB) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.

Is PACB in an uptrend or downtrend?

As of 2026-10-26, PACB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is PACB's trailing P/E ratio?

PACB's trailing P/E is -3.21, with a market cap of 0.43B. See the earnings research page for full valuation detail.

When does PACB next report earnings?

PACB is next scheduled to report earnings on 2026-08-03.